Asher Winder

884 total citations
21 papers, 551 citations indexed

About

Asher Winder is a scholar working on Hematology, Surgery and Rheumatology. According to data from OpenAlex, Asher Winder has authored 21 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Surgery and 5 papers in Rheumatology. Recurrent topics in Asher Winder's work include Platelet Disorders and Treatments (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Asher Winder is often cited by papers focused on Platelet Disorders and Treatments (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Asher Winder collaborates with scholars based in Israel, United Kingdom and Slovakia. Asher Winder's co-authors include Eliezer A. Rachmilewitz, Hussam Ghoti, Johnny Amer, Eitan Fibach, Amiram Eldor, Gisele Zandman‐Goddard, Shachaf Shiber, Eugene R. Katz, Zelig Tochner and Baruch El‐Ad and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and Ophthalmology.

In The Last Decade

Asher Winder

20 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Asher Winder Israel	11	228	134	121	121	75	21	551
Ingrid Pabinger-Fasching Austria	14	502 2.2×	187 1.4×	80 0.7×	102 0.8×	14 0.2×	46	757
Meenakshi Sachdeva India	11	80 0.4×	79 0.6×	84 0.7×	23 0.2×	69 0.9×	34	509
Jorge Martínez-Ara Spain	12	112 0.5×	165 1.2×	85 0.7×	51 0.4×	14 0.2×	27	695
P H Schur United States	9	91 0.4×	219 1.6×	51 0.4×	156 1.3×	11 0.1×	12	490
Éstelle Desport France	12	122 0.5×	39 0.3×	375 3.1×	91 0.8×	8 0.1×	38	610
Styliani I. Kokori Greece	7	178 0.8×	143 1.1×	16 0.1×	28 0.2×	20 0.3×	7	341
Robert L. Seigle United States	10	36 0.2×	83 0.6×	191 1.6×	46 0.4×	15 0.2×	13	591
Georgios Kartalis Greece	9	187 0.8×	100 0.7×	117 1.0×	57 0.5×	4 0.1×	9	559
Katalin Rajczy Hungary	15	100 0.4×	66 0.5×	79 0.7×	74 0.6×	6 0.1×	54	705
Maria Fernanda Soares Brazil	14	105 0.5×	75 0.6×	146 1.2×	53 0.4×	4 0.1×	42	793

Countries citing papers authored by Asher Winder

Since Specialization

Citations

This map shows the geographic impact of Asher Winder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asher Winder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asher Winder more than expected).

Fields of papers citing papers by Asher Winder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asher Winder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asher Winder. The network helps show where Asher Winder may publish in the future.

Co-authorship network of co-authors of Asher Winder

This figure shows the co-authorship network connecting the top 25 collaborators of Asher Winder. A scholar is included among the top collaborators of Asher Winder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asher Winder. Asher Winder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shiber, Shachaf, et al.. (2019). Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form. Frontiers in Immunology. 10. 941–941. 72 indexed citations

Tocut, Milena, et al.. (2019). The complexity of an overlap type resistant cryoglobulinemia: a case report and review of the literature. Clinical Rheumatology. 38(5). 1257–1262. 6 indexed citations

Eikelboom, John W., S. Kozek-Langenecker, A. Exadaktylos, et al.. (2017). Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants. British Journal of Anaesthesia. 120(4). 645–656. 20 indexed citations

Tamir, Sharon Ovnat, Yehudah Roth, Udi Cinamon, et al.. (2015). Laryngeal Side Effects of Tyrosine Kinase Inhibitors. Journal of Voice. 30(5). 606–610. 2 indexed citations

Ghoti, Hussam, Johnny Amer, Asher Winder, Eliezer A. Rachmilewitz, & Eitan Fibach. (2007). Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome. European Journal Of Haematology. 79(6). 463–467. 90 indexed citations

Konen, Eli, et al.. (2007). No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2* technique. American Journal of Hematology. 82(11). 1013–1016. 60 indexed citations

Ghoti, Hussam, Johnny Amer, Asher Winder, E. A. Rachmilewitz, & Eitan Fibach. (2007). P032 Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome. Leukemia Research. 31. S58–S58. 1 indexed citations

Winder, Asher, Hussam Ghoti, Merav Leiba, et al.. (2006). Urinary Hepcidin Excretion in Patients with Myelodysplastic Syndrome (MDS) and Myelofibrosis (MF).. Blood. 108(11). 2620–2620. 3 indexed citations

Fibach, Eitan, Hussam Ghoti, Johnny Amer, Asher Winder, & Eliezer A. Rachmilewitz. (2006). Oxidative Stress in Red Blood Cells, Platelets and Polymorphonuclear Leukocytes from Patients with Myelodysplastic Syndrome.. Blood. 108(11). 2632–2632. 1 indexed citations

10.

Winder, Asher, et al.. (2002). [Anthrax--an overview at 2002].. PubMed. 141 Spec No. 63–72, 121, 120. 1 indexed citations

11.

Neil, H. A. W., et al.. (1999). A pilot study of garlic consumption shows no significant effect on markers of oxidation or sub-fraction composition of low-density lipoprotein including lipoprotein(a) after allowance for non-compliance and the placebo effect. Clinica Chimica Acta. 285(1-2). 21–33. 33 indexed citations

12.

Goldstein, Michaela, et al.. (1999). Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. Ophthalmology. 106(9). 1817–1820. 36 indexed citations

13.

Winder, Asher, et al.. (1998). High-Dose Intravenous γ-Globulins for Heparin-Induced Thrombocytopenia: A Prompt Response. Journal of Clinical Immunology. 18(5). 330–334. 29 indexed citations

14.

Bulvik, Shlomo, Asher Winder, Ofira Ben‐Tal, Amir Szold, & Amiram Eldor. (1998). High-Dose Dexamethasone for Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura. Pathophysiology of Haemostasis and Thrombosis. 28(5). 256–259. 4 indexed citations

15.

Winder, Asher, et al.. (1997). Bilateral Retinal Vein Occlusion Associated With 5,10-Methylenetetrahydrofolate Reductase Mutation. American Journal of Ophthalmology. 124(6). 840–841. 23 indexed citations

16.

Solodky, Alejandro, et al.. (1996). Increased adhesiveness of peripheral blood leukocytes corresponds to the appearance of expansion following anterior wall myocardial infarction. Clinical Cardiology. 19(2). 102–104. 3 indexed citations

17.

Lev, D., et al.. (1995). Increase in leukocyte adhesiveness and aggregation with stress: a model of human congestive heart failure.. PubMed. 62(4). 298–301. 1 indexed citations

18.

Seed, Mary, F. Mailly, D. Vallance, et al.. (1994). Lipoprotein lipase activity in patients with combined hyperlipidaemia. Journal of Molecular Medicine. 72(2). 100–106. 20 indexed citations

19.

Winder, Asher, et al.. (1993). Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases.. PubMed. 20(3). 495–8. 53 indexed citations

20.

El‐Ad, Baruch, et al.. (1990). The Persistence of Neutralizing Antibodies after Revaccination against Smallpox. The Journal of Infectious Diseases. 161(3). 446–448. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact